Combined predictive value of chronic pain and high-sensitivity C-reactive protein for cardiovascular risk
CSTR:
Author:
Affiliation:

(1.Clinical Medicine Department, School of Medicine, South China University of Technology, Guangzhou 510006, China;2.Department of Cardiology, Sixth Medical Centre of Chinese PLA General Hospital, Beijing 100037, China;3.Chinese PLA Medical School, Beijing 100853, China;4.Department of Cardiology, Affiliated Hospital of Xuzhou Medical University, Xuzhou 221200, Jiangsu Province, China;5.Clinical Medicine Department, School of Medicine, Nankai University, Tianjin 300071, China)

Clc Number:

Fund Project:

This work was supported by National Natural Science Foundation of China(82070434/H0214).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective To explore the combined predictive value of chronic pain and high-sensitivity C-reactive protein (hsCRP) for cardiovascular disease (CVD) and develop a novel prediction model for CVD. Methods The study enrolled 3 041 participants aged 45 years or older from China Health and Retirement Longitudinal Study (CHARLS) 2015-2020 database. Chronic pain was defined as recurrent or persistent body pain. Participants were divided into four groups based on chronic pain status and hsCRP levels:no pain and hsCRP <2 mg/L, no pain and hsCRP ≥2 mg/L, pain and hsCRP <2 mg/L, pain and hsCRP ≥2 mg/L. CVD was defined as heart disease and/or stroke diagnosed by the physicians. R 4.3.0 was used for data analysis. Intergroup comparison was performed using ANOVA test, Kruskal-Wallis test, orχ2 test depending on data type. Logistic regression analysis was used to investigate the relationship between chronic pain and hsCRP and CVD risk. Lasso regression method was employed for variable screening. Selected features was used in logistic regression and machine learning modeling. Likelihood ratio test evaluated the interaction between chronic pain and hsCRP. Results Individuals with chronic pain and hsCRP < 2 mg/L had a higher CVD risk than those with no pain and hsCRP < 2 mg/L (OR=2.22,95%CI 1.59-3.10; P<0.001). The CVD risk was highest in individuals with chronic pain and hsCRP≥ 2 mg/L (OR=3.21,95%CI 2.12-4.85; P<0.001). However, there was no statistically significant difference in individuals with no pain and hsCRP≥ 2 mg/L (P=0.091). There was no interaction between chronic pain and hsCRP in increasing CVD risk (likelihood ratio test:P=0.688). Using machine learning with Random Forests, a prediction model combining chronic pain, hsCRP, and traditional CVD risk factors performed well, with an area under the receiver operating characteristic curve of 0.944 and an area under the precision-recall curve of 0.865. Conclusion The combination of chronic pain and high hsCRP level is a strong CVD predictor in the middle-aged and elderly population. Comprehensive assessment of chronic pain and hsCRP in CVD should strengthened to better understand patients′ health status and develop more effective prevention and treatment strategies.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:September 26,2024
  • Revised:
  • Adopted:
  • Online: September 22,2025
  • Published:
Article QR Code